ProfileGDS4718 / 239633_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 67% 53% 71% 65% 51% 50% 66% 64% 70% 62% 69% 56% 48% 49% 59% 58% 52% 53% 63% 66% 60% 59% 64% 62% 49% 66% 56% 65% 52% 53% 51% 67% 63% 56% 48% 54% 62% 66% 54% 61% 56% 54% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6413467
GSM549102patient 115, normal, homogenized [OPG study]6.6116667
GSM549104patient 119, normal, homogenized [OPG study]5.6849453
GSM549108patient 138, normal, homogenized [OPG study]6.9267271
GSM549119patient 077, normal, homogenized [OPG study]6.4521965
GSM549133patient 032, cancer, homogenized [OPG study]5.5109451
GSM549139patient 042, cancer, homogenized [OPG study]5.4968550
GSM549099patient 107, normal, homogenized [OPG study]6.5498766
GSM549109patient 139, normal, homogenized [OPG study]6.3876264
GSM549110patient 046, normal, homogenized [OPG study]6.8088770
GSM549114patient 063, normal, homogenized [OPG study]6.2534862
GSM549122patient 082, normal, homogenized [OPG study]6.8482669
GSM549134patient 033, cancer, homogenized [OPG study]5.8280156
GSM549136patient 036, cancer, homogenized [OPG study]5.3753848
GSM549140patient 044, cancer, homogenized [OPG study]5.4539149
GSM549111patient 047, normal, homogenized [OPG study]6.0482159
GSM549113patient 057, normal, homogenized [OPG study]5.9739358
GSM549132patient 031, cancer, homogenized [OPG study]5.6425652
GSM549137patient 038, cancer, homogenized [OPG study]5.6714253
GSM549142patient 047, cancer, homogenized [OPG study]6.421463
GSM549100patient 110, normal, homogenized [OPG study]6.5315966
GSM549107patient 135, normal, homogenized [OPG study]6.1219260
GSM549115patient 068, normal, homogenized [OPG study]6.0277759
GSM549116patient 072, normal, homogenized [OPG study]6.394164
GSM549120patient 078, normal, homogenized [OPG study]6.2595662
GSM549131patient 030, cancer, homogenized [OPG study]5.4081549
GSM549118patient 074, normal, homogenized [OPG study]6.5913666
GSM549129patient 027, cancer, homogenized [OPG study]5.8775956
GSM549123patient 088, normal, homogenized [OPG study]6.5038465
GSM549124patient 006, cancer, homogenized [OPG study]5.6470652
GSM549126patient 015, cancer, homogenized [OPG study]5.6919553
GSM549128patient 025, cancer, homogenized [OPG study]5.5470351
GSM549103patient 117, normal, homogenized [OPG study]6.6292967
GSM549117patient 073, normal, homogenized [OPG study]6.2461563
GSM549138patient 041, cancer, homogenized [OPG study]5.8708156
GSM549141patient 045, cancer, homogenized [OPG study]5.3751148
GSM549130patient 028, cancer, homogenized [OPG study]5.7440354
GSM549101patient 111, normal, homogenized [OPG study]6.3214262
GSM549105patient 128, normal, homogenized [OPG study]6.5714266
GSM549106patient 134, normal, homogenized [OPG study]5.7075254
GSM549112patient 048, normal, homogenized [OPG study]6.1541661
GSM549125patient 011, cancer, homogenized [OPG study]5.8658456
GSM549127patient 024, cancer, homogenized [OPG study]5.7473954
GSM549135patient 035, cancer, homogenized [OPG study]5.1239244